A randomised, placebo-controlled, Phase II, dose-ranging trial of once-daily treatment with olodaterol, a novel long-acting β2-agonist, for 4 weeks in patients with chronic obstructive pulmonary disease
Treatment of Persistent Asthma With Symbicort® (Budesonide/Formoterol Inhalation Aerosol): An Inhaled Corticosteroid and Long-Acting β2-Adrenergic Agonist in One Pressurized Metered-Dose Inhaler
Comparative study on the pregnancy outcomes of in vitro fertilization–embryo transfer between long-acting gonadotropin-releasing hormone agonist combined with transvaginal ultrasound-guided cyst aspiration and long-acting gonadotropin-releasing hormone agonist alone
Appropriate use of inhaled corticosteroid and long-acting ß2-adrenergic agonist combination therapy among asthma patients in a US commercially insured population
Real-world effects of two inhaled corticosteroid/long-acting β2-agonist combinations in the treatment of asthma
Efficacy and Safety of Inhaled Corticosteroids in Combination with a Long‐Acting Beta2‐Agonist in Asthmatic Children Under Age 5
